Key result
Low dose, prolonged infusion of tissue plasminogen activator uneventfully treated a 42-year-old woman presenting with acute ST-elevation inferior myocardial infarction due to coronary embolism.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Low-dose, prolonged infusion of tissue plasminogen activator can be an effective treatment for coronary embolism and acute STEMI resulting from non-obstructive prosthetic mitral valve thrombosis.
The risk of systemic embolisation in patients with prosthetic heart valves who are receiving anticoagulation therapy is 0.5 to 1.7% per patient year and most cases present with cerebrovascular events. Here we report the case of a 42-year-old woman who was uneventfully treated with a low dose, prolonged infusion of tissue plasminogen activator because of non-obstructive prosthetic mitral valve thrombosis. It presented as coronary embolism and resulted in acute ST-elevation inferior myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Aykan et al. (2012) conducted a case report in Acute ST-elevation inferior myocardial infarction due to non-obstructive mechanical mitral valve thrombosis (n=1). Tissue plasminogen activator was evaluated on Clinical outcome. Low dose, prolonged infusion of tissue plasminogen activator uneventfully treated a 42-year-old woman presenting with acute ST-elevation inferior myocardial infarction due to coronary embolism.
Synapse has enriched 10 related papers. Consider them for comparative context: